首页> 外国专利> pacap (pituitary adenylate cyclase activating polypeptide) based ophthalmic preparations that regain normal visual function in early glaucoma

pacap (pituitary adenylate cyclase activating polypeptide) based ophthalmic preparations that regain normal visual function in early glaucoma

机译:基于pacap(垂体腺苷酸环化酶激活多肽)的眼科制剂,可在青光眼早期恢复正常的视觉功能

摘要

pacap (adenylate cyclase activating pituitary polypeptide) -based ophthalmic preparations which restore normal visual function in early glaucoma normal vision in retinal dystrophy / retinopathy and optic neuropathy, with special reference to glaucoma. said preparations may be administered topically to the surface of the intact eye, and are useful in treating various forms of retinal dystrophy / retinopathy and optic neuropathy such as glaucoma.
机译:基于pacap(腺苷酸环化酶激活垂体多肽)的眼科制剂,可恢复早期青光眼的正常视觉功能,包括视网膜营养不良/视网膜病变和视神经病变,特别是青光眼。所述制剂可以局部施用于完整的眼睛表面,并且可用于治疗各种形式的视网膜营养不良/视网膜病和视神经病如青光眼。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号